Drug shortages

Arsenic Trioxide Injection

Fresenius Kabi USA, LLC

To Be Discontinued63323-637-10Oncology
Open FDA's page for this record
Discontinued date
09/21/2026
Update type
New
Initial posting date
09/21/2026
Package NDC
63323-637-10
Generic name
Arsenic Trioxide Injection
Contact info
888-386-1300
Related info
Discontinuation of the manufacture of the drug
Update date
09/21/2026
Dosage form
Injection
Presentation
Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)
Company name
Fresenius Kabi USA, LLC
Status
To Be Discontinued
Therapeutic category
Oncology
Harmonized identifiers (openFDA)
Application number
ANDA208231
Brand name
ARSENIC TRIOXIDE
Generic name
ARSENIC TRIOXIDE
Manufacturer name
Fresenius Kabi USA, LLC
Product NDC
63323-637
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
ARSENIC TRIOXIDE
RxCUI
829926
SPL ID
1ed1c170-ee7f-4f96-98dd-041657d3bdd8
SPL set ID
a482eccd-8837-47ea-904d-2f2c294d10fa
Package NDC
63323-637-03, 63323-637-10
UNII
S7V92P67HO
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.